Dataset from A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009271
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this multi-center study in non-dialysis participants with anemia associated
with CKD is to evaluate safety, efficacy and quality of life of daprodustat compared to
placebo.
创建时间：
2024-11-26
